Altered GLUT4 Translocation in Skeletal Muscle of 12/15-Lipoxygenase Knockout Mice

Abstract

We have recently shown that 12(S)-hydroxyeicosatetraenoic acid plays a role in the organization of actin microfilaments in rat cardiomyocytes, and that inhibition of 12-lipoxygenase abrogates insulin-stimulated GLUT4 translocation in these cells. In the present study, we used mice that were null for the leukocyte 12/15-lipoxygenase to explore the implications of this enzyme for insulin action under in vivo conditions. Insulin induced a profound reduction in blood glucose in both control and knockout mice. However, significantly higher serum insulin levels were observed in these animals. GLUT4 expression in heart and skeletal muscle was unaffected in KO mice. Insulin-regulated serine phosphorylation of Akt and GSK3α and GSK3β was unaltered in heart and skeletal muscle of knockout mice, suggesting unaltered insulin signaling. Fractionation of hind limb muscles showed that insulin had induced a prominent translocation of GLUT4 to skeletal muscle plasma membranes in control mice. However, this response was largely reduced in knockout animals. Our data show that the lack of leukocyte 12/15-lipoxygenase does not lead to the development of an insulin-resistant phenotype. However, perturbation of GLUT4 translocation in skeletal muscle of knockout mice may indicate latent insulin resistance, and supports our hypothesis that eicosanoids are involved in insulin-mediated regulation of muscle glucose transport.

12/15-lipoxygenase - knockout mouse - GLUT4 translocation - insulin resistance

References

• 1 Bjornholm M, Zierath J R. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.  Biochem Soc Trans. 2005;  33 354-357
• 2 Krebs M, Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature.  Diabetes Obes Metab. 2005;  7 621-632
• 3 Zorzano A, Palacin M, Guma A. Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle.  Acta Physiol Scand. 2005;  183 43-58
• 4 Tsakiridis T, Vranic M, Klip A. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane.  J Biol Chem. 1994;  269 29 934-29 942
• 5 Wang Q, Bilan P J, Tsakiridis T, Hinek A, Klip A. Actin filaments participate in the relocalization of phosphatidylinositol-3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes.  Biochem J. 1998;  331 917-928
• 6 Torok D, Patel N, Jebailey L, Thong F S, Randhawa V K, Klip A, Rudich A. Insulin but not PDGF relies on actin remodeling and on VAMP2 for GLUT4 translocation in myoblasts.  J Cell Sci. 2004;  117 5447-5455
• 7 Kang L T, Phillips T M, Vanderhoek J Y. Novel Membrane Target Proteins for Lipoxygenase-Derived Mono(S)hydroxy Fatty Acids.  Biochim Biophys Acta. 1999;  1438 388-398
• 8 Rice R L, Tang D G, Haddad M, Honn K V, Taylor J D. 12(S)-hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: a protein kinase-dependent process.  Int J Cancer. 1998;  77 271-278
• 9 Miller Y I, Chang M K, Funk C D, Feramisco J R, Witztum J L. 12/15-lipoxygenase translocation enhances site-specific actin polymerization in macrophages phagocytosing apoptotic cells.  J Biol Chem. 2001;  276 19 431-19 439
• 10 Miller Y I, Worrall D S, Funk C D, Feramisco J R, Witztum J L. Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.  Mol Biol Cell. 2003;  14 4196-4206
• 11 Brash A R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate.  J Biol Chem. 1999;  274 23 679-23 682
• 12 Kuhn H, Thiele B J. The diversity of the lipoxygenase family. Many sequence data but little information on biological significance.  FEBS Lett. 1999;  449 7-11
• 13 Freire-Moar J, Alavi-Nassab A, Ng M, Mulkins M, Sigal E. Cloning and characterization of a murine macrophage lipoxygenase.  Biochim Biophys Acta. 1995;  1254 112-116
• 14 Breitbart E, Sofer Y, Shainberg A, Grossman S. Lipoxygenase activity in heart cells.  FEBS Lett.. 1996;  395 148-152
• 15 Dransfeld O, Rakatzi I, Sasson S, Gruzman A, Schmitt M, Haussinger D, Eckel J. Eicosanoids participate in the regulation of cardiac glucose transport by contribution to a rearrangement of actin cytoskeletal elements.  Biochem J. 2001;  359 47-54
• 16 Dransfeld O, Rakatzi I, Sasson S, Eckel J. Eicosanoids and the regulation of cardiac glucose transport.  Ann NY Acad Sci. 2002;  967 208-216
• 17 Sun D, Funk C D. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein.  J Biol Chem. 1996;  271 24 055-24 062
• 18 Ledwig D, Muller H, Bischoff H, Eckel J. Early acarbose treatment ameliorates resistance of insulin-regulated GLUT4 trafficking in obese Zucker rats.  Eur J Pharmacol. 2002;  445 141-148
• 19 Reddy M A, Kim Y S, Lanting L, Natarajan R. Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice.  Hypertension. 2003;  41 1294-1300
• 20 Anning P B, Coles B, Bermudez-Fajardo A, Martin P E, Levison B S, Hazen S L, Funk C D, Kuhn H, O'Donnell V B. Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.  Am J Pathol. 2005;  166 653-662
• 21 Funk C D, Cyrus T. 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis.  Trends Cardiovasc Med. 2001;  11 116-124
• 22 George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk C D, Sigal E, Harats D. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice.  Circulation. 2001;  104 1646-1650
• 23 Cyrus T, Witztum J L, Rader D J, Tangirala R, Fazio S, Linton M F, Funk C D. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.  J Clin Invest. 1999;  103 1597-1604
• 24 Bleich D, Chen S, Zipser B, Sun D, Funk C D, Nadler J L. Resistance to Type 1 Diabetes Induction in 12-Lipoxygenase Knockout Mice.  J Clin Invest. 1999;  103 1431-1436
• 25 Uphues I, Kolter T, Goud B, Eckel J. Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins.  Biochem J. 1995;  311 161-166
• 26 Rudich A, Klip A. Push/pull mechanisms of GLUT4 traffic in muscle cells.  Acta Physiol Scand. 2003;  178 297-308
• 27 Holman G D, Sandoval I V. Moving the insulin-regulated glucose transporter GLUT4 into and out of storage.  Trends Cell Biol. 2001;  11 173-179
• 28 Whiteman E L, Cho H, Birnbaum M J. Role of Akt/protein kinase B in metabolism.  Trends Endocrinol Metab. 2002;  13 444-451